SCHEMBL1845409

SCHEMBL1845409

C/C=C/C(=O)OCCc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.73
AKR1B10 O60218 6/20 0.69
AKR1B1 P15121 6/20 0.69
MAOB P27338 1/20 0.61
ALOX5 P09917 5/20 0.57
TTR P02766 4/20 0.57
CYP3A4 P08684 2/20 0.57
ALOX15 P16050 2/20 0.57
ALOX12 P18054 2/20 0.57
MAPK1 P28482 2/20 0.57
HSD17B10 Q99714 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
GMNN O75496 1/20 0.57
ALDH1A1 P00352 1/20 0.57
EGFR P00533 1/20 0.57
LMNA P02545 1/20 0.57
ESR1 P03372 1/20 0.57
ERBB2 P04626 1/20 0.57
APP P05067 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1845413 1.00 HCAR2 (0.73) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL3482701 0.89 HCAR2 (0.89) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL573377 0.89 HCAR2 (0.89) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL9860306 0.89 HCAR2 (0.89) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL26120528 0.89 HCAR2 (0.67) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL4672346 0.86 HCAR2 (0.67) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL27735855 0.85 HCAR2 (0.76) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL16672651 0.85 HCAR2 (0.53) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL25623741 0.85 HCAR2 (0.76) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL10886450 0.85 AKR1B10 (0.58) HCAR2AKR1B10AKR1B1MAOBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220142158-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2022-05-12 US claimed
CN-113905612-A Arthropod control composition 弗门尼舍有限公司 2022-01-07 CN claimed
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2026-04-09 US disclosed
EP-4489592-B1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2025-12-24 EP disclosed
US-20250255827-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-08-14 US disclosed
EP-4593639-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION Xampla Limited (GB) 2025-08-06 EP disclosed
US-20250186960-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-12 US disclosed
EP-3888782-B1 COATED MICROCAPSULES NOXELL CORP (US) 2025-06-11 EP disclosed
US-20250177298-A1 EMULSIONS AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-05 US disclosed
WO-2025109106-A1 CORE-SHELL MICROCAPSULES XAMPLA Ltd. (GB) 2025-05-30 WO disclosed
EP-4489717-A1 EMULSIONS AND A METHOD FOR THEIR PREPARATION Xampla Limited (GB) 2025-01-15 EP disclosed
EP-1905787-A2 Polymer latex of high acrylonitrile content, film, pattern forming material and lithographic printing plate precursor using the same, and method for production of polymer latex FUJIFILM Corporation (JP) 2008-04-02 EP disclosed
US-7268160-B2 Remedies TAKARA BIO, INC. (JP) 2007-09-11 US disclosed
US-7268160-B2 Remedies TAKARA BIO, INC. (JP) 2007-09-11 US disclosed
EP-1765139-A1 ROLLER FOR PROVIDING BENEFITS TO FABRIC The Procter and Gamble Company (US) 2007-03-28 EP disclosed
US-20060041078-A1 Alkali-soluble gap filling material forming composition for lithography NISSAN CHEMICAL INDUSTRIES, LTD 2006-02-23 US disclosed
WO-2006010087-A1 ROLLER FOR PROVIDING BENEFITS TO FABRIC THE PROCTER & GAMBLE COMPANY (US) 2006-01-26 WO disclosed
US-20060005333-A1 Roller for providing benefits to fabric PROCTER & GAMBLE COMPANY, THE 2006-01-12 US disclosed
EP-1586945-A1 ALKALI-SOLUBLE GAP FILLING MATERIAL FORMING COMPOSITION FOR LITHOGRAPHY Nissan Chemical Industries, Ltd. (JP) 2005-10-19 EP disclosed
US-20030232259-A1 Dye-containing curable composition, color filter, and producing process thereof FUJI PHOTO FILM CO., LTD. 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION PCTP, CLK4, MTCL3 HCAR2 4673/4885AKR1B10 4746/4885AKR1B1 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.